Alexion Pharmaceuticals
$113.309876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$113.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.13 (-0.99%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell ALXN and other stocks, options, ETFs, and crypto commission-free!
About ALXN
Alexion Pharmaceuticals, Inc. Common Stock, also called Alexion Pharmaceuticals, is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Read More Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA. The listed name for ALXN is Alexion Pharmaceuticals, Inc. Common Stock.
Employees
3,082
Headquarters
Boston, Massachusetts
Founded
1992
Market Cap
24.83B
Price-Earnings Ratio
30.58
Dividend Yield
—
Average Volume
2.91M
High Today
$115.76
Low Today
$112.73
Open Price
$115.75
Volume
1.29M
52 Week High
$121.50
52 Week Low
$72.67
Collections
Analyst Ratings
59%
of 22 ratings
Buy
59%
Hold
41%
Sell
0%
ALXN Earnings
$0.00
$1.07
$2.15
$3.22
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Oct 21, Pre-Market